| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.036 | 0.4 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |